OpenHIE has scheduled its annual community meeting for November 12-16 in Colombo, Sri Lanka. The annual event brings together global health professionals to foster connections and share experiences to build digital ecosystems that support secure and accurate information storage and exchange. OpenHIE is a global initiative focused on supporting the use of data exchange standards and the implementation of health system interoperability to improve healthcare in low-resource environments. https://lnkd.in/eHXZu8iw
Regenstrief Institute, Inc.
Research Services
Indianapolis, IN 5,786 followers
Research to transform health systems and communities for a healthier, more equitable world.
About us
Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes. Research focuses include informatics, aging and health services. The Regenstrief Institute, Inc. is a not-for-profit health care research organization located in downtown Indianapolis, Indiana. It is closely affiliated with the Indiana University School of Medicine, Roudebush VA Medical Center, IU Health, and Eskenazi Health among other research partners. Be sure to visit the website, https://www.regenstrief.org, to see more of its work to improve global healthcare.
- Website
-
http://www.regenstrief.org
External link for Regenstrief Institute, Inc.
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Indianapolis, IN
- Type
- Nonprofit
- Founded
- 1969
- Specialties
- Medical Informatics, Healthcare Research, Interoperability, Implementation Science, Health Services Research, and Aging Research
Locations
-
Primary
1101 West 10th Street
Indianapolis, IN 46202-2872, US
-
1101 West 10th Street
Indianapolis, IN 46202-3012, US
Employees at Regenstrief Institute, Inc.
Updates
-
Michael Weiner, M.D., MPH, emphasizes the importance of understanding when opioids are the best option for treating chronic cough. While opioids can be effective, more research is needed to explore alternative treatments for certain patients. https://lnkd.in/gUx__Jpk
-
Dr. Paul Musey is a new research scientist in the Center for Health Services Research at Regenstrief Institute. His clinical research interests surround the evaluation and management of psychological contributors to emergency department treatment. Dr. Musey is the Eskenazi Health Foundation Scholar of Emergency Medicine and Vice Chair of Research and Innovation for the IU School of Medicine Department of Emergency Medicine. https://lnkd.in/gfKq2sY2
-
Regenstrief researcher Paul Biondich, M.D., M.S., attended the first in-person Africa e-Health Leadership Forum in Nairobi, Kenya. The forum aimed to build consensus on digital health leadership and governance and to create a community where African e-health leaders can share knowledge with their peers in an open and safe environment.
-
Andrew Gonzalez, M.D., J.D., MPH, of Regenstrief and IU School of Medicine has been named a 2024 National Academy of Medicine in Diagnostic Excellence Scholar in Diagnostic Excellence. He is one of 11 individuals nationwide selected for this prestigious mid-career program. Dr. Gonzalez will develop an AI method to identify asymptomatic patients with peripheral arterial disease, a leading cause of limb amputations. https://lnkd.in/gi7b9_vv
-
Regenstrief affiliate scientist Dr. Emily Webber is an IBJ Tech Executive of the Year for her work advancing technology at IU Health. She led efforts to connect care teams and patients during the pandemic, collaborated with the Indiana Department of Health to establish 24/7 Doc2Doc support for pediatric care teams and implemented innovative technology for patient engagement and research support. Her leadership has modernized patient care and strengthened health equity across Indiana. https://lnkd.in/g7GFnAvU
-
Regenstrief researcher Nicole R. Fowler, PhD, MHSA, of Regenstrief and IU School of Medicine, and Michelle Mielke, PhD, of Wake Forest University School of Medicine, outline factors to be considered in preparation for widespread implementation of Alzheimer's biomarker testing in real-world, clinical populations. Biomarkers could revolutionize Alzheimer's diagnosis, but key questions remain about use, accuracy and ethics. https://lnkd.in/gg7SRGjh
-
David Haggstrom, M.D., MAS, of Regenstrief, IU School of Medicine and Veterans Administration Medical Center in Indianapolis highlights the need to address anxiety faced by patients with low-risk cancers undergoing active surveillance. His JAMA Oncology article calls for interventions like cognitive therapy and mindfulness to manage the stress of waiting for test results. https://lnkd.in/gCQvVMbW
-
Dr. Tarik Yuce is a new research scientist in the Center for Health Services Research at Regenstrief Institute. His research focus is in the medical and surgical treatment of obesity, with a particular interest in issues surrounding the delivery of timely care. Dr. Yuce is a bariatric surgeon and health services researcher who serves as an assistant professor of surgery in the Division of General Surgery at the IU School of Medicine. https://lnkd.in/gVgxeC9n
-
A study led by Johanne Eliacin, PhD, reveals a lack of awareness of Alzheimer's disease among older Black Americans and proposes strategies to support brain health in this community. Understanding and addressing these challenges is crucial for creating culturally sensitive solutions. https://lnkd.in/g8T4Nzbf